期刊文献+

中国厦门地区献血者细小病毒B19感染情况研究 被引量:11

Prevalence of Parvovirus B19 Infection in Chinese Xiamen Area Blood Donors
下载PDF
导出
摘要 目的:了解中国厦门地区献血者细小病毒B19感染情况。方法:对中国厦门地区部分献血者标本进行细小病毒B19核酸检测和抗体检测,对核酸检测阳性标本进行序列测定和基因型分析。结果:在总共10 452人份献血者标本中检出6例B19核酸阳性,阳性率0.06%,阳性标本的DNA定量结果为3.59×102-1.07×104IU/ml;6例核酸阳性标本测序分析结果均为基因I型。B19-Ig M抗体阳性率为4.64%(50/1078),B19-Ig G阳性率16.79%(181/1078);B19-Ig G阳性率随年龄增加而升高(χ2=7.964,P〈0.05),与性别差异无关。结论:中国厦门地区献血者细小病毒的总体感染率较其他地区偏低,但也存在一定比例的病毒血症,在今后的输血保障工作中应引起重视。 Objective:To estimate the prevalence of parvovirus B19 infection in Chinese Xiamen area blood donors.Methods:Blood samples from blood donors were tested for detection of parvovirus B19 DNA and antibody.The direct sequencing and genetype analysis of B19 DNA positive samples were performed.Results:Six out of 10452 samples were B19 DNA positive.The viral loads of the 6 samples were between 3.59×102-1.07×104 IU/ml;the positive rate of B19-IgM was 4.64%(50/1 078) and B19-IgG was 16.79%(181/1078).The positive rate of B19-IgG increased with ages,and was not related with the sex.Conclusion:The overall prevalence of parvovirus B19 infection in blood donors is lower in Chinese Xiamen area than that in other areas,however,there is still a certain percentage of viremia in donors and the attention should be paid to blood safety in the future work.
机构地区 厦门市中心血站
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2016年第5期1572-1576,共5页 Journal of Experimental Hematology
基金 福建省自然科学基金面上项目(2012D049) 厦门市输血医学重点专科项目(2012-2014)
关键词 细小病毒B19 病毒感染 献血者 核酸检测 中国厦门地区 parvovirus B19 virus infection blood donor NAT Chinese Xiamen area
  • 相关文献

参考文献7

二级参考文献66

  • 1Candotti D, Etiz N, Parsyan A, et al. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol,2004,78(22) :12169.
  • 2Serjeant GR,Serjeat BE ,Thomas PW,et al. Human parvovirus infection in homozygous sickle ceil disease. Lancet, 1993, 341 (8855) : 1237-1240.
  • 3Corcoran A, Doyle S. Advances in the biology, diagnosis and hostpathogen interaction of parvovirus B19. J Med Microbiol, 2004,53 (6) : 459-475.
  • 4Beatric J,Tiangco MD,Joseph E,et al. The human parvovirus B19 in transfusion medicine. Transfusion medicine Update, 1996, 8 (1) : 241-244.
  • 5Aubin JT, Defer C, Vidaud M, et al. Large-scale screening for human parvovirus B19 DNA by PCR: application to the quality control of plasma for fractionation. Vox Sang,2000,78( 1 ) :7-12.
  • 6Bonvieini F, Gallinella G, Cricca M, et al. Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus. J Med Virol,2004,74(2):272.
  • 7Tabor E, Yu MY, Hewlett I, et al. Summary of a workshop on the implementation of NAT to screen donors of blood and plasma for viruses[ J]. Transfusion, 2000,40(10) : 1273-1275.
  • 8Bltimel J, Schmidt I, Effenberger W, et al. Parvovims B19 transmission by heat-treated clotting factor concentrates. Transfusion, 2002, 42( 1 ) : 1473-1481.
  • 9Wu CG, Mason B, Jong J, et al. Parvovirus B19 transmission by a high-purity factor Ⅷ concentrates. Transfusion, 2005, 45 (6) : 1003-1010.
  • 10Geng Y, Wu CG, Bhattacharyya SP, et al. Parvovirus B19 DNA in Factor Ⅷ concentrates: effects of manufacturing procedures and B19 screening by nucleic acidtesting. Transfusion, 2007, 47 (5) : 883-889.

共引文献44

同被引文献69

引证文献11

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部